These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23470611)

  • 21. Quetiapine-induced reversible sick sinus syndrome.
    Chou PH; Lin CC; Lee CP; Lan TH; Chan CH
    Psychiatry Clin Neurosci; 2010 Aug; 64(4):444-5. PubMed ID: 20653914
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
    Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H
    J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.
    Baune BT; Caliskan S; Todder D
    Hum Psychopharmacol; 2007 Jan; 22(1):1-9. PubMed ID: 17191266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quetiapine not quiet-a-pine--not a sleeper.
    Zarowitz BJ
    Geriatr Nurs; 2011; 32(1):46-8. PubMed ID: 21295716
    [No Abstract]   [Full Text] [Related]  

  • 25. [No quetiapine for sleeping disorders].
    Tak LM; van Berlo-van de Laar IR; Doornbos B
    Ned Tijdschr Geneeskd; 2013; 157(4):A5740. PubMed ID: 23343742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somnambulism secondary to olanzapine treatment in one patient with bipolar disorder.
    Chiu YH; Chen CH; Shen WW
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):581-2. PubMed ID: 18006134
    [No Abstract]   [Full Text] [Related]  

  • 27. Low dose quetiapine in the treatment of an adolescent with somnambulism: a case report.
    Gill JS; Pillai SK; Koh OH; Jambunathan ST
    Acta Neurol Belg; 2011 Jun; 111(2):155-6. PubMed ID: 21748939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restless legs syndrome following the combined use of quetiapine and paroxetine.
    Chou KJ; Chen PY; Huang MC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1139-40. PubMed ID: 20470847
    [No Abstract]   [Full Text] [Related]  

  • 29. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
    Vieta E; Calabrese JR; Goikolea JM; Raines S; Macfadden W;
    Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Symptoms after withdrawal of quetiapine].
    Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1770. PubMed ID: 23097888
    [No Abstract]   [Full Text] [Related]  

  • 31. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
    Vieta E; Mullen J; Brecher M; Paulsson B; Jones M
    Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
    Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR;
    J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term functioning and sleep quality in patients with major depressive disorder treated with extended-release quetiapine fumarate.
    Sheehan DV; Locklear J; Svedsäter H; Datto C
    Int Clin Psychopharmacol; 2012 Sep; 27(5):239-48. PubMed ID: 22859063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pedal edema associated with addition of low-dose quetiapine to valproate treatment in bipolar disorder.
    Chen CY; Yeh YW; Kuo SC; Shiah IS; Liu PY; Chen CL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1551-2. PubMed ID: 19665043
    [No Abstract]   [Full Text] [Related]  

  • 35. Somnambulism due to probable interaction of valproic acid and zolpidem.
    Sattar SP; Ramaswamy S; Bhatia SC; Petty F
    Ann Pharmacother; 2003 Oct; 37(10):1429-33. PubMed ID: 14519043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
    Riesenberg RA; Baldytcheva I; Datto C
    Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quetiapine-associated hyperglycemia and hypertriglyceridemia.
    Domon SE; Cargile CS
    J Am Acad Child Adolesc Psychiatry; 2002 May; 41(5):495-6. PubMed ID: 12014779
    [No Abstract]   [Full Text] [Related]  

  • 39. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1980 Sep; 22(19):77-84. PubMed ID: 6106886
    [No Abstract]   [Full Text] [Related]  

  • 40. Quetiapine-induced mania.
    Pacchiarotti I; Manfredi G; Kotzalidis GD; Girardi P; Tatarelli R
    Aust N Z J Psychiatry; 2003 Oct; 37(5):626. PubMed ID: 14511093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.